Clonal Complexity Defines Distinct Tumor‐Intrinsic Biology and Prognosis in Diffuse Large B‐Cell Lymphoma
Open Access
- 2 February 2026
- journal article
- Published by Wiley in Cancer Medicine
- Vol. 15 (2) , e71597
Abstract
Background: Intratumor heterogeneity (ITH), characterized by the coexistence of genetically distinct subclones within a tumor, has been associated with adverse clinical outcomes in various cancers. However, the clinical and biological implications of ITH in diffuse large B‐cell lymphoma (DLBCL) are still incompletely understood. Materials & Methods: In this study, we applied a SNP‐array–based approach to assess the clonal complexity in formalin‐fixed, paraffin‐embedded tumor specimens obtained from newly diagnosed patients with advanced‐stage DLBCL ( n = 74) by calculating the clonal composition (CC) number. Rseults: Patients with Poly‐CC tumors (CC ≥ 1), which accounted for 79.7% of the cases, had a 5‐year event‐free survival rate of 38.9%, compared with 69.1% in those with Mono‐CC tumors (CC = 0) (Log‐rank p = 0.0520). This association reached statistical significance in the activated B‐cell (ABC) subtype ( n = 35, Log‐rank p = 0.0450) but not in the germinal center B‐cell (GCB) subtype ( n = 30, Log‐rank p = 0.910). Gene set enrichment analysis revealed upregulation of cell cycle–related pathways in Poly‐CC tumors, consistent with the significantly higher Ki‐67 positivity rate than in Mono‐CC tumors, as confirmed by immunohistochemistry ( p = 0.00227). Within the ABC subtype, Poly‐CC (Poly‐ABC) tumors exhibited more differentiated transcriptional states and enrichment of IRF4‐associated gene signatures as compared with Mono‐CC (Mono‐ABC) tumors. Conversely, IFN‐γ and IFN‐α response pathways and the IL‐6/JAK‐STAT3 signaling pathway were markedly suppressed in the Poly‐ABC tumors. Furthermore, Poly‐ABC tumors carried a significantly higher number of pathogenic mutations as compared with Mono‐ABC tumors ( p = 0.0147). Conclusion: These results suggest that clonal complexity captures tumor‐intrinsic features and biological diversity in DLBCL, especially in the ABC subtype, offering novel insights into the disease pathogenesis.Keywords
This publication has 50 references indexed in Scilit:
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- IRF4: Immunity. Malignancy! Therapy?Clinical Cancer Research, 2009
- A Signaling Pathway Mediating Downregulation of BCL6 in Germinal Center B Cells Is Blocked by BCL6 Gene Alterations in B Cell LymphomaCancer Cell, 2007
- Methods and strategies for analyzing copy number variation using DNA microarraysNature Genetics, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Array CGH technologies and their applications to cancer genomesChromosome Research, 2005
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learningNature Medicine, 2002
- Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma CellsJournal of Experimental Medicine, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000